tirzepatide and birth control pills (MOUNJARO® / ZEPBOUND®) Important Information About Pregnancy Prevention If you are taking tirzepatide (Mounjaro® or Zepbound®) and use birth control pills, there is an important medication interaction Tirzepatide Pills: Daily Oral Tablets

Semaglutide has shown remarkable results in clinical trials, helping patients lose an average of 15% of body weight over 68 weeks

Use a journal or an app to document your weight loss journey and celebrate any milestones or achievements along the way

CNP can block the synthesis of VEGF induced by hypoxia and endothelin at the transcriptional level, thereby inhibiting VEGF-mediated hyperplasia of endothelial cells

In separate large obesity trials, semaglutide 2.4mg led to 14.9% mean weight loss at 68 weeks in STEP-1 (n=1,961), while tirzepatide 15mg led to 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (n=2,539)